CrisprBits

CrisprBits is an Indian biotech startup pioneering CRISPR-based diagnostics and gene editing for healthcare. Their PathCrisp platform enables rapid detection of antibiotic resistance (e.g., NDM) in 2 hours, far quicker than traditional methods, with demonstrated 100% agreement with gold standard tests. They are also developing next-generation CAR-T cells, disease tissue models from edited iPSCs, and aim to extend CRISPR to climate-impacting applications in food and fermentation. The company emphasizes affordable, high-quality solutions for India and beyond, operates prominent labs in Bengaluru, and is recognized by DPIIT as a startup. Clinical validation is underway, but no late-stage (Phase 2/3/NDA) pipeline items are public yet.